APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nimodipine Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nimodipine Injection Market Analysis and Forecast 2026-2032

29 December 2025192 pages

Choose your research edition.

Industry ResearchNimodipine Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Nimodipine Injection Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Nimodipine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nimodipine Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Nimodipine Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nimodipine Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nimodipine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nimodipine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nimodipine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nimodipine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nimodipine Injection include Huiyu Pharmaceutical, Bayer, Lexicare Pharma, Cisen Pharmaceutical and Actiza Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nimodipine Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nimodipine Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Nimodipine Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nimodipine Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nimodipine Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nimodipine Injection sales, projected growth trends, production technology, application and end-user industry.

Nimodipine Injection Segment by Company

Huiyu Pharmaceutical

Bayer

Lexicare Pharma

Cisen Pharmaceutical

Actiza Pharmaceutical

Nimodipine Injection Segment by Type

50ml:10mg

100ml:20mg

Nimodipine Injection Segment by Application

Hospital

Clinic

Nimodipine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nimodipine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nimodipine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nimodipine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nimodipine Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nimodipine Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nimodipine Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nimodipine Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50ml:10mg Major Manufacturers Table 3. 100ml:20mg Major Manufacturers Table 4. Global Nimodipine Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Nimodipine Injection Industry Trends Table 8. Nimodipine Injection Industry Drivers Table 9. Nimodipine Injection Industry Opportunities and Challenges Table 10. Nimodipine Injection Industry Restraints Table 11. Global Nimodipine Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Nimodipine Injection Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Nimodipine Injection Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Nimodipine Injection Revenue Market Share by Region (2021-2026) Table 15. Global Nimodipine Injection Revenue Market Share by Region (2027-2032) Table 16. Global Nimodipine Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Nimodipine Injection Sales by Region (2021-2026) & (K Units) Table 18. Global Nimodipine Injection Sales by Region (2027-2032) & (K Units) Table 19. Global Nimodipine Injection Sales Market Share by Region (2021-2026) Table 20. Global Nimodipine Injection Sales Market Share by Region (2027-2032) Table 21. Global Nimodipine Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Nimodipine Injection Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Nimodipine Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Nimodipine Injection Sales Market Share by Manufacturers (2021-2026) Table 25. Global Nimodipine Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Nimodipine Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Nimodipine Injection Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Nimodipine Injection Manufacturers, Product Type & Application Table 29. Global Nimodipine Injection Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Nimodipine Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Nimodipine Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Nimodipine Injection Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Nimodipine Injection Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Nimodipine Injection Revenue Market Share by Type (2021-2026) Table 36. Global Nimodipine Injection Revenue Market Share by Type (2027-2032) Table 37. Global Nimodipine Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Nimodipine Injection Sales by Type (2021-2026) & (K Units) Table 39. Global Nimodipine Injection Sales by Type (2027-2032) & (K Units) Table 40. Global Nimodipine Injection Sales Market Share by Type (2021-2026) Table 41. Global Nimodipine Injection Sales Market Share by Type (2027-2032) Table 42. Global Nimodipine Injection Price by Type (2021-2026) & (US$/Unit) Table 43. Global Nimodipine Injection Price by Type (2027-2032) & (US$/Unit) Table 44. Global Nimodipine Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Nimodipine Injection Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Nimodipine Injection Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Nimodipine Injection Revenue Market Share by Application (2021-2026) Table 48. Global Nimodipine Injection Revenue Market Share by Application (2027-2032) Table 49. Global Nimodipine Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Nimodipine Injection Sales by Application (2021-2026) & (K Units) Table 51. Global Nimodipine Injection Sales by Application (2027-2032) & (K Units) Table 52. Global Nimodipine Injection Sales Market Share by Application (2021-2026) Table 53. Global Nimodipine Injection Sales Market Share by Application (2027-2032) Table 54. Global Nimodipine Injection Price by Application (2021-2026) & (US$/Unit) Table 55. Global Nimodipine Injection Price by Application (2027-2032) & (US$/Unit) Table 56. Huiyu Pharmaceutical Company Information Table 57. Huiyu Pharmaceutical Business Overview Table 58. Huiyu Pharmaceutical Nimodipine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Huiyu Pharmaceutical Nimodipine Injection Product Portfolio Table 60. Huiyu Pharmaceutical Recent Development Table 61. Bayer Company Information Table 62. Bayer Business Overview Table 63. Bayer Nimodipine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Bayer Nimodipine Injection Product Portfolio Table 65. Bayer Recent Development Table 66. Lexicare Pharma Company Information Table 67. Lexicare Pharma Business Overview Table 68. Lexicare Pharma Nimodipine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Lexicare Pharma Nimodipine Injection Product Portfolio Table 70. Lexicare Pharma Recent Development Table 71. Cisen Pharmaceutical Company Information Table 72. Cisen Pharmaceutical Business Overview Table 73. Cisen Pharmaceutical Nimodipine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Cisen Pharmaceutical Nimodipine Injection Product Portfolio Table 75. Cisen Pharmaceutical Recent Development Table 76. Actiza Pharmaceutical Company Information Table 77. Actiza Pharmaceutical Business Overview Table 78. Actiza Pharmaceutical Nimodipine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Actiza Pharmaceutical Nimodipine Injection Product Portfolio Table 80. Actiza Pharmaceutical Recent Development Table 81. North America Nimodipine Injection Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Nimodipine Injection Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Nimodipine Injection Sales by Type (2021-2026) & (K Units) Table 84. North America Nimodipine Injection Sales by Type (2027-2032) & (K Units) Table 85. North America Nimodipine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 86. North America Nimodipine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 87. North America Nimodipine Injection Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Nimodipine Injection Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Nimodipine Injection Sales by Application (2021-2026) & (K Units) Table 90. North America Nimodipine Injection Sales by Application (2027-2032) & (K Units) Table 91. North America Nimodipine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 92. North America Nimodipine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 93. North America Nimodipine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Nimodipine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Nimodipine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Nimodipine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 97. North America Nimodipine Injection Sales by Country (2021-2026) & (K Units) Table 98. North America Nimodipine Injection Sales by Country (2027-2032) & (K Units) Table 99. North America Nimodipine Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 100. North America Nimodipine Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 101. United States Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 102. Canada Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 103. Mexico Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 104. Europe Nimodipine Injection Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Nimodipine Injection Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Nimodipine Injection Sales by Type (2021-2026) & (K Units) Table 107. Europe Nimodipine Injection Sales by Type (2027-2032) & (K Units) Table 108. Europe Nimodipine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 109. Europe Nimodipine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 110. Europe Nimodipine Injection Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Nimodipine Injection Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Nimodipine Injection Sales by Application (2021-2026) & (K Units) Table 113. Europe Nimodipine Injection Sales by Application (2027-2032) & (K Units) Table 114. Europe Nimodipine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 115. Europe Nimodipine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 116. Europe Nimodipine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Nimodipine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Nimodipine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Nimodipine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. Europe Nimodipine Injection Sales by Country (2021-2026) & (K Units) Table 121. Europe Nimodipine Injection Sales by Country (2027-2032) & (K Units) Table 122. Europe Nimodipine Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 123. Europe Nimodipine Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 124. Germany Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 125. France Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 126. U.K. Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 127. Italy Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 128. Russia Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 129. Spain Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 132. Sweden Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 133. Poland Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 134. China Nimodipine Injection Revenue by Type (2021-2026) & (US$ Million) Table 135. China Nimodipine Injection Revenue by Type (2027-2032) & (US$ Million) Table 136. China Nimodipine Injection Sales by Type (2021-2026) & (K Units) Table 137. China Nimodipine Injection Sales by Type (2027-2032) & (K Units) Table 138. China Nimodipine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Nimodipine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Nimodipine Injection Revenue by Application (2021-2026) & (US$ Million) Table 141. China Nimodipine Injection Revenue by Application (2027-2032) & (US$ Million) Table 142. China Nimodipine Injection Sales by Application (2021-2026) & (K Units) Table 143. China Nimodipine Injection Sales by Application (2027-2032) & (K Units) Table 144. China Nimodipine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Nimodipine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Nimodipine Injection Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Nimodipine Injection Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Nimodipine Injection Sales by Type (2021-2026) & (K Units) Table 149. Asia Nimodipine Injection Sales by Type (2027-2032) & (K Units) Table 150. Asia Nimodipine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Nimodipine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Nimodipine Injection Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Nimodipine Injection Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Nimodipine Injection Sales by Application (2021-2026) & (K Units) Table 155. Asia Nimodipine Injection Sales by Application (2027-2032) & (K Units) Table 156. Asia Nimodipine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Nimodipine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Nimodipine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Nimodipine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Nimodipine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Nimodipine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Nimodipine Injection Sales by Country (2021-2026) & (K Units) Table 163. Asia Nimodipine Injection Sales by Country (2027-2032) & (K Units) Table 164. Asia Nimodipine Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Nimodipine Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 167. South Korea Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 168. India Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 169. Australia Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Nimodipine Injection Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Nimodipine Injection Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Nimodipine Injection Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Nimodipine Injection Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Nimodipine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Nimodipine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Nimodipine Injection Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Nimodipine Injection Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Nimodipine Injection Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Nimodipine Injection Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Nimodipine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Nimodipine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Nimodipine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Nimodipine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Nimodipine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Nimodipine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Nimodipine Injection Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Nimodipine Injection Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Nimodipine Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Nimodipine Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 193. Argentina Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 194. Chile Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 195. Colombia Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 196. Peru Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 198. Israel Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 199. UAE Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 200. Turkey Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 201. Iran Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 202. Egypt Nimodipine Injection Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Nimodipine Injection Distributors List Table 206. Nimodipine Injection Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Nimodipine Injection Image Figure 2. Global Nimodipine Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nimodipine Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50ml:10mg Image Figure 5. 100ml:20mg Image Figure 6. Global Nimodipine Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Nimodipine Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Nimodipine Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Nimodipine Injection Revenue (2021-2032) & (US$ Million) Figure 12. Global Nimodipine Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Nimodipine Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Nimodipine Injection Revenue Market Share by Region (2021-2032) Figure 15. Global Nimodipine Injection Sales (2021-2032) & (K Units) Figure 16. Global Nimodipine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Nimodipine Injection Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Nimodipine Injection Sales YoY (2021-2032) & (K Units) Figure 19. Europe Nimodipine Injection Sales YoY (2021-2032) & (K Units) Figure 20. China Nimodipine Injection Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Nimodipine Injection Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Nimodipine Injection Sales YoY (2021-2032) & (K Units) Figure 23. Global Nimodipine Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Nimodipine Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Nimodipine Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Nimodipine Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Nimodipine Injection Revenue Market Share by Type (2021-2032) Figure 29. Global Nimodipine Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Nimodipine Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Nimodipine Injection Sales Market Share by Type (2021-2032) Figure 32. Global Nimodipine Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Nimodipine Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Nimodipine Injection Revenue Market Share by Application (2021-2032) Figure 35. Global Nimodipine Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Nimodipine Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Nimodipine Injection Sales Market Share by Application (2021-2032) Figure 38. North America Nimodipine Injection Revenue Share by Type (2021-2032) Figure 39. North America Nimodipine Injection Sales Share by Type (2021-2032) Figure 40. North America Nimodipine Injection Revenue Share by Application (2021-2032) Figure 41. North America Nimodipine Injection Sales Share by Application (2021-2032) Figure 42. North America Nimodipine Injection Revenue Share by Country (2021-2032) Figure 43. North America Nimodipine Injection Sales Share by Country (2021-2032) Figure 44. Europe Nimodipine Injection Revenue Share by Type (2021-2032) Figure 45. Europe Nimodipine Injection Sales Share by Type (2021-2032) Figure 46. Europe Nimodipine Injection Revenue Share by Application (2021-2032) Figure 47. Europe Nimodipine Injection Sales Share by Application (2021-2032) Figure 48. Europe Nimodipine Injection Revenue Share by Country (2021-2032) Figure 49. Europe Nimodipine Injection Sales Share by Country (2021-2032) Figure 50. China Nimodipine Injection Revenue Share by Type (2021-2032) Figure 51. China Nimodipine Injection Sales Share by Type (2021-2032) Figure 52. China Nimodipine Injection Revenue Share by Application (2021-2032) Figure 53. China Nimodipine Injection Sales Share by Application (2021-2032) Figure 54. Asia Nimodipine Injection Revenue Share by Type (2021-2032) Figure 55. Asia Nimodipine Injection Sales Share by Type (2021-2032) Figure 56. Asia Nimodipine Injection Revenue Share by Application (2021-2032) Figure 57. Asia Nimodipine Injection Sales Share by Application (2021-2032) Figure 58. Asia Nimodipine Injection Revenue Share by Country (2021-2032) Figure 59. Asia Nimodipine Injection Sales Share by Country (2021-2032) Figure 60. SAMEA Nimodipine Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA Nimodipine Injection Sales Share by Type (2021-2032) Figure 62. SAMEA Nimodipine Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA Nimodipine Injection Sales Share by Application (2021-2032) Figure 64. SAMEA Nimodipine Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA Nimodipine Injection Sales Share by Country (2021-2032) Figure 66. Nimodipine Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Nimodipine Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml:10mg
  • 100ml:20mg
Applications
  • Hospital
  • Clinic
Companies covered
  • Huiyu Pharmaceutical
  • Bayer
  • Lexicare Pharma
  • Cisen Pharmaceutical
  • Actiza Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nimodipine Injection Market by Type
  3. 1.2.1 Global Nimodipine Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50ml:10mg
  5. 1.2.3 100ml:20mg
  6. 1.3 Nimodipine Injection Market by Application
  7. 1.3.1 Global Nimodipine Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Nimodipine Injection Market Dynamics
  1. 2.1 Nimodipine Injection Industry Trends
  2. 2.2 Nimodipine Injection Industry Drivers
  3. 2.3 Nimodipine Injection Industry Opportunities and Challenges
  4. 2.4 Nimodipine Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nimodipine Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nimodipine Injection Revenue by Region
  3. 3.2.1 Global Nimodipine Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nimodipine Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Nimodipine Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Nimodipine Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nimodipine Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nimodipine Injection Sales by Region
  9. 3.4.1 Global Nimodipine Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nimodipine Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Nimodipine Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Nimodipine Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nimodipine Injection Revenue by Manufacturers
  2. 4.1.1 Global Nimodipine Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nimodipine Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nimodipine Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nimodipine Injection Sales by Manufacturers
  6. 4.2.1 Global Nimodipine Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nimodipine Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nimodipine Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nimodipine Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nimodipine Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nimodipine Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nimodipine Injection Manufacturers, Product Type & Application
  13. 4.7 Global Nimodipine Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nimodipine Injection Market CR5 and HHI
  16. 4.8.2 2025 Nimodipine Injection Tier 1, Tier 2, and Tier 3
5 Nimodipine Injection Market by Type
  1. 5.1 Global Nimodipine Injection Revenue by Type
  2. 5.1.1 Global Nimodipine Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nimodipine Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nimodipine Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nimodipine Injection Sales by Type
  6. 5.2.1 Global Nimodipine Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nimodipine Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nimodipine Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nimodipine Injection Price by Type
6 Nimodipine Injection Market by Application
  1. 6.1 Global Nimodipine Injection Revenue by Application
  2. 6.1.1 Global Nimodipine Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nimodipine Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nimodipine Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nimodipine Injection Sales by Application
  6. 6.2.1 Global Nimodipine Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nimodipine Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nimodipine Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nimodipine Injection Price by Application
7 Company Profiles
  1. 7.1 Huiyu Pharmaceutical
  2. 7.1.1 Huiyu Pharmaceutical Company Information
  3. 7.1.2 Huiyu Pharmaceutical Business Overview
  4. 7.1.3 Huiyu Pharmaceutical Nimodipine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Huiyu Pharmaceutical Nimodipine Injection Product Portfolio
  6. 7.1.5 Huiyu Pharmaceutical Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Nimodipine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Nimodipine Injection Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 Lexicare Pharma
  14. 7.3.1 Lexicare Pharma Company Information
  15. 7.3.2 Lexicare Pharma Business Overview
  16. 7.3.3 Lexicare Pharma Nimodipine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lexicare Pharma Nimodipine Injection Product Portfolio
  18. 7.3.5 Lexicare Pharma Recent Developments
  19. 7.4 Cisen Pharmaceutical
  20. 7.4.1 Cisen Pharmaceutical Company Information
  21. 7.4.2 Cisen Pharmaceutical Business Overview
  22. 7.4.3 Cisen Pharmaceutical Nimodipine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Cisen Pharmaceutical Nimodipine Injection Product Portfolio
  24. 7.4.5 Cisen Pharmaceutical Recent Developments
  25. 7.5 Actiza Pharmaceutical
  26. 7.5.1 Actiza Pharmaceutical Company Information
  27. 7.5.2 Actiza Pharmaceutical Business Overview
  28. 7.5.3 Actiza Pharmaceutical Nimodipine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Actiza Pharmaceutical Nimodipine Injection Product Portfolio
  30. 7.5.5 Actiza Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Nimodipine Injection Market Size by Type
  2. 8.1.1 North America Nimodipine Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Nimodipine Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Nimodipine Injection Price by Type (2021-2032)
  5. 8.2 North America Nimodipine Injection Market Size by Application
  6. 8.2.1 North America Nimodipine Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Nimodipine Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Nimodipine Injection Price by Application (2021-2032)
  9. 8.3 North America Nimodipine Injection Market Size by Country
  10. 8.3.1 North America Nimodipine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nimodipine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nimodipine Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Nimodipine Injection Market Size by Type
  2. 9.1.1 Europe Nimodipine Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nimodipine Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Nimodipine Injection Price by Type (2021-2032)
  5. 9.2 Europe Nimodipine Injection Market Size by Application
  6. 9.2.1 Europe Nimodipine Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nimodipine Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Nimodipine Injection Price by Application (2021-2032)
  9. 9.3 Europe Nimodipine Injection Market Size by Country
  10. 9.3.1 Europe Nimodipine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nimodipine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nimodipine Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Nimodipine Injection Market Size by Type
  2. 10.1.1 China Nimodipine Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Nimodipine Injection Sales by Type (2021-2032)
  4. 10.1.3 China Nimodipine Injection Price by Type (2021-2032)
  5. 10.2 China Nimodipine Injection Market Size by Application
  6. 10.2.1 China Nimodipine Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Nimodipine Injection Sales by Application (2021-2032)
  8. 10.2.3 China Nimodipine Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nimodipine Injection Market Size by Type
  2. 11.1.1 Asia Nimodipine Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nimodipine Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Nimodipine Injection Price by Type (2021-2032)
  5. 11.2 Asia Nimodipine Injection Market Size by Application
  6. 11.2.1 Asia Nimodipine Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nimodipine Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Nimodipine Injection Price by Application (2021-2032)
  9. 11.3 Asia Nimodipine Injection Market Size by Country
  10. 11.3.1 Asia Nimodipine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nimodipine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nimodipine Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nimodipine Injection Market Size by Type
  2. 12.1.1 SAMEA Nimodipine Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nimodipine Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nimodipine Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Nimodipine Injection Market Size by Application
  6. 12.2.1 SAMEA Nimodipine Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nimodipine Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nimodipine Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Nimodipine Injection Market Size by Country
  10. 12.3.1 SAMEA Nimodipine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nimodipine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nimodipine Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nimodipine Injection Value Chain Analysis
  2. 13.1.1 Nimodipine Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nimodipine Injection Production Mode & Process
  6. 13.2 Nimodipine Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nimodipine Injection Distributors
  9. 13.2.3 Nimodipine Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst